Overview
- Health Universe closed a $6M seed round led by Kleiner Perkins, bringing total funding to $9.5M and targeting expansion across academic medical centers, health systems, and life sciences organizations.
- The company highlights ONC B.11 certification, TEFCA participation, SOC 2 Type II compliance, and HIPAA alignment as core enablers for deploying autonomous and human‑in‑the‑loop agents in regulated settings.
- In a company‑reported Duke Clinical Research Institute pilot, Project Loom cut trial setup from six–nine months to about 7.5 days, with 93% time savings and 10x faster document processing.
- Health Universe stresses that ONC B.11 covers decision‑support transparency and is distinct from FDA clearance, and independent validation will be important to confirm reported efficiency gains.
- The platform spans Navigator, Explorer, and Observer with oncology and clinical‑trials agents, has processed over 170 million clinical documents since launch, and includes a developing Agent‑to‑Agent Marketplace for secure inter‑organizational workflows.